Novavax stock jumps after company settles dispute over canceled Covid vaccine purchase

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization…

Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

Moderna on Thursday posted a surprise quarterly profit, boosted by deferred revenue and cost cuts, even…

‘This is the mental health moment’: Innovation and M&A are helping to boost these stocks to new heights

There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall,…

What Eli Lilly investors can learn from the slow launch of a competitor’s drug

Club holding Eli Lilly is expecting to get approval for its Alzheimer’s treatment in the coming…

Healthy Returns: Higher medical costs are pinching insurers

A UnitedHealth Group health insurance card is seen in a wallet, Oct.14, 2019. Lucy Nicholson |…

Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue…

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo,…

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas…

CVS beats estimates, but cuts full-year profit outlook on higher medical costs

CVS Health on Wednesday reported fourth-quarter revenue and adjusted earnings that topped expectations, but the company…

Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes

Good afternoon! All eyes are on Novo Nordisk and Eli Lilly again as Wall Street looks for signs that they can…

Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City,…

Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City,…

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio…

Novo Nordisk hits $500 billion in market value as it flags soaring demand for Wegovy, Ozempic

Liselotte Sabroe | Afp | Getty Images Novo Nordisk on Wednesday reported better-than-expected 2023 earnings, as…

Pfizer beats earnings estimates as declining Covid business loses less revenue than expected

Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit, as the company’s declining Covid business performed…